Cargando…
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
BACKGROUND: Nebivolol is a third-generation beta-blocker used to treat hypertension. The vasodilation properties of nebivolol have been attributed to nitric oxide (NO) release. However, the kinetics and mechanism of nebivolol-stimulated bioavailable NO are not fully understood. METHODS: Using ampero...
Autores principales: | Mason, R Preston, Jacob, Robert F, Corbalan, J Jose, Szczesny, Damian, Matysiak, Kinga, Malinski, Tadeusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856588/ https://www.ncbi.nlm.nih.gov/pubmed/24074014 http://dx.doi.org/10.1186/2050-6511-14-48 |
Ejemplares similares
-
Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects
por: Corbalan, J Jose, et al.
Publicado: (2011) -
Variable Effects Of LDL Subclasses Of Cholesterol On Endothelial Nitric Oxide/Peroxynitrite Balance – The Risks And Clinical Implications For Cardiovascular Disease
por: Hua, Jiangzhou, et al.
Publicado: (2019) -
Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D(3) – clinical implications for cardiovascular diseases
por: Khan, Alamzeb, et al.
Publicado: (2018) -
Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps
por: Manda-Handzlik, Aneta, et al.
Publicado: (2019) -
Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)